Novartis CEO Says AI Could Shorten Drug Development to Eight Years
AI summary
Novartis CEO Vasant Narasimhan told Bloomberg that AI could cut drug-development time from 12 years to eight and significantly improve the odds of bringing medicines to market. He said AI is already helping Novartis speed up clinical trials, analyze data and identify new drug candidates.
This source provides an excerpt. Continue reading on the original site.